Moderna has been awarded approximately $590 million from the federal government to help speed up the development of an ...
The current public-health risk is low, but the CDC is watching the situation carefully and working with states to monitor ...
The US Department of Health and Human Services will award $590 million to Moderna to continue developing a vaccine to protect ...
The package will provide additional support for late-stage development and licensure of pre-pandemic mRNA-based vaccines, the ...
The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country ...
Given the uncertainty regarding its top-line growth, we would advise short-term investors to steer clear of MRNA stock.
Moderna receives $590M contract from HHS for mRNA-based bird flu vaccine; up 4% in after-hours trading. Read more here.
Shares of Moderna (NASDAQ:MRNA) jumped 5% following reports that it had been awarded $590 million for the development of a ...
Moderna (MRNA) announced ongoing support from the U.S. Department of Health and Human Services, HHS, to accelerate the development of ...
Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...
Moderna secured a $590 million package from the U.S. Health and Human Services Department to accelerate the development of its bird influenza vaccine as concerns about a bird flu pandemic in humans ...